New hope for kids with rare copper deficiency disease
NCT ID NCT04074512
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This program gives children under 6 with Menkes disease access to copper histidinate injections. Menkes disease is a rare genetic disorder where the body cannot properly use copper, leading to severe developmental problems. The treatment aims to supply the missing copper to help manage the condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
copper histidinate (CUTX-101)
What this could lead to
If this treatment works, it could help manage Menkes disease by providing the copper the body needs, potentially improving survival and development in young children.
What could go wrong
This is an expanded access program, not a controlled trial, so results are not definitive. The treatment may not work for all patients, and side effects from copper therapy are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENKES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
-
Connecticut Children's Medical Center
Hartford, Connecticut, 06106, United States
-
Cook Children's Health Care System
Fort Worth, Texas, 76104, United States
-
Duke University Hospital
Durham, North Carolina, 27710, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503, United States
-
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, 33701, United States
-
Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
Maine Medical Center
Portland, Maine, 04102, United States
-
Memorial Healthcare Systems
Hollywood, Florida, 33021, United States
-
Monroe Carrell Jr. Children's Hospital at Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
Shodair Children's Hospital
Helena, Montana, 59601, United States
-
University of California Davis Medical Center
Sacramento, California, 95817, United States
-
University of Iowa Stead Family Children's Hospital
Iowa City, Iowa, 52242, United States